Surgical Mask to Prevent Influenza Transmission in Households: A Cluster Randomized Trial by Canini, Laetitia et al.
Surgical Mask to Prevent Influenza Transmission in
Households: A Cluster Randomized Trial
Laetitia Canini














1UMR-S 707, UPMC – Paris 6, Paris, France, 2U707, Inserm, Paris, France, 3Laboratoire de Virologie Me ´dicale et Mole ´culaire, Centre Hospitalier Universitaire de Reims,
Reims, France, 4EA-4303, Faculte ´ de Me ´decine, Reims, France, 5Unite ´ de Sante ´ Publique de L’ho ˆpital Saint-Antoine, Assistance Publique Ho ˆpitaux de Paris, Paris, France,
6Cire Aquitaine, Institut de Veille Sanitaire, Bordeaux, France, 7Cabinet Me ´dical, Audincourt, France, 8Urgences Me ´dicales de Paris, Paris, France, 9SOS Me ´decins, Paris,
France
Abstract
Background: Facemasks and respirators have been stockpiled during pandemic preparedness. However, data on their
effectiveness for limiting transmission are scarce. We evaluated the effectiveness of facemask use by index cases for limiting
influenza transmission by large droplets produced during coughing in households.
Methodology and Principal Findings: A cluster randomized intervention trial was conducted in France during the 2008–
2009 influenza season. Households were recruited during a medical visit of a household member with a positive rapid
influenza A test and symptoms lasting less than 48 hours. Households were randomized either to the mask or control group
for 7 days. In the intervention arm, the index case had to wear a surgical mask from the medical visit and for a period of 5
days. The trial was initially intended to include 372 households but was prematurely interrupted after the inclusion of 105
households (306 contacts) following the advice of an independent steering committee. We used generalized estimating
equations to test the association between the intervention and the proportion of household contacts who developed an
influenza-like illness during the 7 days following the inclusion. Influenza-like illness was reported in 24/148 (16.2%) of the
contacts in the intervention arm and in 25/158 (15.8%) of the contacts in the control arm and the difference between arms
was 0.40% (95%CI: 210% to 11%, P=1.00). We observed a good adherence to the intervention. In various sensitivity
analyses, we did not identify any trend in the results suggesting effectiveness of facemasks.
Conclusion: This study should be interpreted with caution since the lack of statistical power prevents us to draw formal
conclusion regarding effectiveness of facemasks in the context of a seasonal epidemic.
Trial Registration: clinicaltrials.gov NCT00774774
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Introduction
Influenza virus is responsible for annual epidemics worldwide
and causes a significant public health burden. Influenza virus is
transmitted by direct contact with infected individuals, exposure to
virus-contaminated objects (fomites), and inhalation of infectious
aerosols [1]. The threat of a severe H5N1 pandemic caused by
avian influenza and the recent worldwide spreading of influenza
H1N1v have renewed interests in nonpharmaceutical interven-
tions for limiting influenza transmission. Hand sanitizers, face-
masks and respirators have been stockpiled during pandemic
preparedness and are currently recommended in several countries.
However, data on their effectiveness for limiting transmission are
scarce. Five randomized trials evaluating facemasks and hand
hygiene with different designs and objectives have been recently
published [2,3,4,5,6]. Three of these trials were conducted in
families and did not show significant improvements in their
primary analyses in intervention groups versus the control groups
[2,3,4]. However, in these trials, secondary analysis suggested that
intervention using face masks could have a significant effectiveness
if implemented rapidly from illness onset or providing a good
adherence to the intervention [7].
In this study, we evaluated the effectiveness of surgical
facemasks for limiting influenza transmission by large droplets
produced during coughing. A clustered design was justified
since the intervention was randomly assigned to a household
member and outcomes were measured in their household
contacts.
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The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Population description, eligibility and enrollment
We conducted a cluster-randomized controlled trial in which
households were randomly allocated to a surgical mask arm
(intervention) or a control (non-intervention) arm. The mask had
to be worn by the index case only. The intervention was targeted
at the household level, and the outcomes were measured at the
individual level in household subjects. The households were
selected by 62 general practitioners, who were volunteers to
participate to the study.
The study was conducted in 3 French regions (Ile de France,
Aquitaine and Franche-Comte ´) during the 2008–09 influenza
season period – defined as the period when the national incidence
of influenza-like illness (ILI) reported on the French national
influenza surveillance Sentinelles system was above a calculated
threshold [8].
Households of size 3 to 8 were eligible. Households were
recruited by general practitioners (GP) when one member (the
index patient) aged over 5 years old had a medical visit with the
GP for symptoms lasting less than 48 hours, combining temper-
ature over 37.8uC and cough, and a positive rapid test for
influenza A (Quick ViewH Influenza A+B Test, Quidel Corp., San
Diego, CA, USA). The index patient had to be a priori the first and
unique illness case in the household and be affiliated to the French
national health insurance. Households were not eligible if the
index patient was treated for asthma or chronic obstructive
pulmonary disease or was hospitalized. Written informed consent
was obtained from the index patient before rapid testing. Proxy
written consent from parents or legal guardians was obtained for
persons 17 years or younger, with additional written assent from
those 13 to 17 years of age and eventually from those 7 to 13 years
old. The GP graded each symptom and sign exhibited by the
index patient from 0=none, 1=mild, 2=moderate, and
3=intense. In each household, a referent adult member accepted
the follow-up responsibility for the trial. The referent member
received a tympanic thermometer with instructions to safely take
the temperature of every household member with this device at
day 0, 3, and 6 or in case of new symptoms. The referent accepted
to complete a questionnaire on a daily basis and during a period of
21 days, with details on symptoms, health care use, quality of life
and social activities of all household members. Instructions were
also given to the referent member to maintain blinding during the
telephone interview.
Ethics statement
The study protocol was approved by the ethics committee
Comite ´ de Protection des Personnes Ile de France XI and was
registered with ClinicalTrials.gov (Identifier NCT00774774).
Randomization
Households were randomized in a 1:1 ratio either to the mask
or control group. Randomization was stratified according to age of
the index patient (,15 years, $15 years) [9] and the French
administrative region. Randomization lists were prepared by a
biostatistician, according to the block randomized method, with
blocks of size 2 to 6.
Randomization lists were generated by a computerized
program. Randomization was performed centrally by the GP
after written consent on an interactive voice response system
dedicated to the study.
Intervention
In case of randomization in the mask group, thirty masks were
given immediately and a demonstration for proper use was given
by the GP. Surgery masks with earloops, 3 plys, anti fog
(AEROKYNH, LCH medical products, Paris, France) were used
for adults and children over 10 years of age. Children facemasks
(Face Mask KC47127, Kimberly-ClarkH, Dallas, TX, USA) were
used for index patients aged 5 to 10 years old. The masks had to be
worn from the medical visit and for a period of 5 days, each time
another household member was in the same room or in a confined
place (e.g. in a car). The index patient did not have to wear the
mask at night. The masks had to be changed every 3 hours, or if
they were damaged, and disposed of in closed plastic bags. In both
groups, the index patient was encouraged to sleep alone in his/her
room. In the control group, no intervention was applied. Seven
days from inclusion, the referent household member was contacted
by phone by a trained investigator. The interview was assisted with
a computer program and was run in two steps: a first step during
which the investigator was blinded to the treatment arm and the
referent member was solicited to report on symptoms (including
temperature), treatment, medical and social outcomes, for every
household member; a second unblinded step during which the
arm was revealed to the investigator and the referent member was
solicited to report on mask use and observance in the index
patient, in case of randomization in the intervention group.
The main objective was to assess the decrease of secondary
illness in household contact in the mask group vs. the control
group. We also focused on the tolerance and feasibility of wearing
masks.
Sample Size
The size of the study assumed an analysis at the individual level,
a proportion of 24% of secondary illness in household contacts and
an intra-cluster correlation of 0.29 [10]. We expected an absolute
decrease of 10% of the attack rate for the contact subjects (a
relative decrease of 42%); this value was considered as clinically
relevant. The mean size of households with more than 3 members
is 3.8 [11]. Therefore, 372 households representing 1042 contacts
and a total of 1414 subjects were necessary to obtain a power of
90%.
Definition of outcomes
The primary endpoint was the proportion of household contacts
who developed an ILI during the 7 days following inclusion. A
temperature over 37.8uC with cough or sore throat was used as
primary clinical case-definition [12]. This definition has been
shown to be specific to influenza infection during seasonal
epidemics [4], but of limited sensitivity. We therefore also used a
more sensitive case-definition (hereafter referred to as the sensitive
ILI definition) based on a temperature over 37.8uC or at least two
of the following: sore throat, cough, runny nose, or fatigue [4]. Post
hoc analyses were conducted by taking into account the time
between symptoms onset in the index patient and allocation to
intervention or by considering ILI that occurred after a minimum
time lag after allocation to intervention [3]. We also studied
whether occurrence of an ILI in the intervention arm was
associated with adherence parameters (such as duration of wearing
a mask). Finally, we explored a cluster level efficacy outcome, the
proportion of households with 1 or more secondary illness in
household contacts. Other analyses were conducted regarding
Facemasks and Influenza
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mask-wearing and the number of masks worn.
Statistical analysis
All analyses were done on an intent-to-treat basis. The rule
missing equal failure was applied for missing outcome values. To
compare study outcomes between arms, we used cluster-specific
method because households rather than patients were random-
ized. The main outcomes were compared at the individual contact
level considering the index case age stratification and a within
household correlation. We estimated 95% CIs of proportions by
using a cluster bootstrap technique with 1000 resamples [13]. We
used an alternating logistic regression model with an exchangeable
log odds ratio to test the multivariate-adjusted association between
the intervention and the outcomes and to identify other predictors
associated with the outcomes [14]. The exchangeable log odds
ratio is a measure of within household correlation and should be
interpreted as a ratio of the odds of a contact to be a secondary
case when another contact in the household is a secondary case to
the odds of a contact to be a secondary case when another contact
is not a secondary case. We used forced-entry methods to include
the allocated group and factors that may not have been well
balanced between arms at baseline, while other potential
predictors were included based on a P-value,0.20 in univariate
analysis and were selected using a backward procedure. Baseline
signs and symptoms of index patients were dichotomized in two
levels, none or mild versus moderate or intense. The Fisher’s exact
test was used to compare proportions. To determine the
compliance factors associated with ILI among contacts tests in
the intervention group, we performed bivariate analyses using
Wilcoxon 2-sample test. For all analyses, a P-value of 0.05 was
considered as statistically significant. Analyses were performed
using SAS v9.1.3 (Sas Institute Inc, Cary, NC, USA)
Early stopping
The trial was initially intended to be conducted during a single
influenza season, during winter 2008–09. In early March 2009,
due to a mild and short influenza season, approximately thirty
percent of the expected number of households had been included,
and the scientific committee of the trial was solicited to decide on
whether or not the accrual period should be extended over the
subsequent influenza season. The decision was to conduct the trial
over the next season. However, as the new H1N1v emerged and
because the French national preparedness included mass distri-
bution of surgical facemasks in households, methodological and
ethical concerns about the possibility to pursue the trial occurred.
In June 2009, the scientific committee requested advice from an
independent steering committee. An unblinded preliminary
analysis was presented to the independent committee during a
closed meeting excluding investigators of the trial and the sponsor,
and the decision was made to stop the trial.
Results
An influenza epidemic caused by seasonal A/Brisbane/10/
2007 (H3N2)-like was announced the 15th December 2008, by the
influenza surveillance systems in France and ended the 22nd
February 2009 [15]. For practical reasons, inclusions in the trial
started just after the national Christmas holidays.
Between January 5
th 2009 to February 16
th 2009, 32 general
practitioners recruited 105 households, which represented 148
contacts in the intervention arm and 158 in the control arm. Two
households were lost to follow-up, one in each arm (Figure 1), they
were considered in the analysis.
The characteristics of the index patients and the household
contacts in the two arms were overall similar (Table 1): 35 (33%) of
index patients were children under 15 years of age, 50 (48%) were
female, and influenza symptoms were well balanced between
arms. The most frequent symptoms (except cough which was one
of the inclusion criteria) were fatigue, headache, myalgia, runny
nose/sneezing, sore throat, lacrimation and earache. The mean
size of the household was 3.961.0. Differences were however
observed concerning the proportion of index patients who were
smokers and the proportion of household contacts less than 15
years in the intervention arm.
Figure 1. Flow diagram.
doi:10.1371/journal.pone.0013998.g001
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Intervention arm Control arm
Index case – number 52 53
Age (years) – mean 6 SD 25616 28616
Age,15 years – n (%) 19 (37) 16 (30)
Sex ratio (M/F) 26/26 29/24
Vaccinated – n (%) 0( 0 ) 2( 4 )
Current smoker: yes – n (%) 15 (29) 2 (4)
Time between symptoms onset and allocation to intervention (hours)
#6–n( % ) 0( 0 ) 1( 2 )
7–12 – n (%) 8 (15) 8 (15)
13–18 – n (%) 13 (25) 10 (19)
19–24 – n (%) 8 (15) 14 (26)
25–36 – n (%) 11 (21) 10 (19)
37–48 – n (%) 10 (19) 9 (17)
Not available – n (%) 2( 4 ) 1( 2 )
Symptoms of the index case*
Fatigue – n (%) 50 (96) 48 (92)
Headache – n (%) 37 (73) 40 (77)
Myalgia – n (%) 38 (73) 38 (73)
Runny nose/sneezing – n (%) 37 (71) 36 (69)
Sore throat – n (%) 24 (46) 21 (40)
Lacrimation – n (%) 18 (35) 22 (42)
Earache – n (%) 4 (8) 5 (10)
Body temperature (uC) - mean 6 SD 38.260.8 38.360.8
Number of household contacts - mean 6 SD 2.861.1 3.061.0
Household contacts – number 148 158
Age (years) – mean 6 SD 29619 25617
Age,15 years – n (%) 41 (28) 62 (39)
Sex ratio (M/F) 73/75 79/79
Vaccinated – n (%) 14 (9) 6 (4)
Current smoker: yes – n (%) 24 (16) 20 (13)
*number (%) of patients exhibiting moderate or intense symptoms.
doi:10.1371/journal.pone.0013998.t001
Table 2. Predictors of ILI among household contacts.
Odds-Ratio 95% CI P-value
Index characteristics
Intervention arm: yes vs. no* 0.95 0.44–2.05 0.90
Current smoker: yes vs. no* 1.83 0.56–5.97 0.32
Runny nose/sneezing: intense or moderate vs. mild or none 4.61 1.44–14.8 0.010
Sore throat: intense or moderate vs. mild or none 2.52 1.15–5.53 0.021
Body temperature: per uC increase 2.04 1.07–3.89 0.030
Contacts characteristics
Age,15 years: yes vs. no* 2.01 1.10–3.66 0.023
Contact’s sex: Male vs. Female 0.40 0.21–0.73 0.0031
*Entry was forced for these variables in the multivariate model.
doi:10.1371/journal.pone.0013998.t002
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148 (16.2%) of the contacts in the intervention arm and in 25/158
(15.8%) of the contacts in the control arm. The difference -of ILI
attack rate between the intervention arm and the control arm was
0.40% (95%CI: 210% to 11%, P=1.00). ILI among contacts
occurred more frequently when moderate or intense sore throat or
runny nose or elevated temperature were reported in the index
patient, and when the household contact was aged less than 15
years old and was female (Table 2). The multivariate adjusted
odds-ratio (OR) for intervention arm vs. control arm was 0.95
(95%CI: 0.44 to 2.05, P=0.90). The common log-odds ratio was
3.66 (95%CI 1.53 to 8.73, P=0.0035). Using the sensitive ILI
definition did not modify the findings: 42/148 (28.4%) of ILI were
observed among the contacts in the intervention arm and 42/158
(26.6%) in the control arm (difference: 21.8%, 95%CI 212% to
14%; P=0.80) and the multivariate adjusted OR for intervention
arm vs. control arm was 0.99 (95%CI: 0.51 to 1.93, p=0.97).
When the analysis was limited to households where the index
patient was allocated to intervention less than 24 hours from
symptoms onset, ILI occurred in 15 of 83 (18.1%) contacts in the
intervention arm vs. 17 of 108 (15.7%) contacts in the control arm
(difference 2.3%, 95%CI 212% to 16%; P=0.70).
When the analysis was limited to an event that appeared more
than 24 hours after inclusion, 12 ILI (9.2%) were reported in 130
contacts in the intervention arm vs. 13 (9.4%) in 138 contacts in
the control arm (difference 20.19%, 95%CI 29.2% to 8.2%;
P=1.00). Using the sensitive ILI definition did not modify the
findings.
The proportion of households with one or more secondary
illness in contacts did not differ between arms. The proportion was
15/52 (29%) in the intervention arm and 18/53 (34%) in the
control arm (difference 25.1%, 95%CI 223% to 13%; P=0.67)
using the primary clinical case-definition. The proportion was 22/
52 (42%) in the intervention arm and 27/53 (51%) in the control
arm (difference 28.6%, 95%CI 228% to 10%; P=0.44) using the
sensitive ILI definition.
In the intervention arm, the index patients reported wearing a
total of 1167.2 masks during 4.061.6 days with an average use of
2.561.3 masks per day and a duration of use of 3.762.7 hours a
day. The adherence to mask-wearing was not associated with the
ILI among contacts (Table 3).
Thirty-eight (75%) patients from the intervention arm reported
discomfort with mask use (Table 4). The three main causes of
discomfort were warmth (45%), respiratory difficulties (33%) and
humidity (33%). Children wearing children facemasks reported
feeling pain more frequently (3/12) than other participants
wearing adult facemasks (1/39) (p=0.036). No difference was
detected concerning the other cause of discomfort depending on
the facemask type.
Discussion
We did not show any significant difference in ILI proportion
among household contacts between the intervention arm and the
control arm. Our study was clearly underpowered due to its
premature termination. The inclusion of 105 households instead of
372 led to 38% power for detecting the hypothesized difference of
10%. There was no laboratory verification of ILI self-reports and
asymptomatic or subclinical infections may have been missed in
addition to including non-influenza events - altogether this may
have contributed to diminish the chance to identify a significant
effect of face masks. As a consequence of the lack of power, the
lower bound of the 95% confidence interval of the multivariate
adjusted odds-ratio was 0.44 meaning that we cannot formally
exclude that our trial could have missed a substantial face masks
effectiveness; i.e. a relative reduction of the ILI attack rate of up to
56%. However we did not identify any trend in the results or
during the numerous secondary analyses suggesting that inclusion
Table 3. Adherence to mask use.
ILI among contacts
(n=22)
No ILI among contacts
(n=124) P value
Total number of masks used – mean 6 SD 9.466.9 11.167.1 0.31
Number of days the mask was worn – mean 6 SD 4.061.6 4.161.5 0.87
Number of masks used each day– mean 6 SD 2.361.2 2.661.2 0.17
Duration of mask wearing by day (in hours) – mean 6 SD 3.262.2 4.062.7 0.098
One household (2 contacts) with missing follow-up information was not included in the calculation.
doi:10.1371/journal.pone.0013998.t003
Table 4. Discomfort due to mask use.
Reported problem
Children mask
(n=12) Adult mask (n=39)*P value
Warmth - n (%) 5 (42) 18 (46) 1.00
Respiratory difficulties - n (%) 2 (17) 15 (39) 0.29
Humidity - n (%) 3 (25) 14 (36) 0.73
Did not like being seen with the mask - n (%) 3 (25) 12 (31) 1.00
Irritation - n (%) 2 (17) 5 (13) 0.66
Pain - n (%) 3 (25) 1 (2.6) 0.036
One index-patient with missing follow-up information was not included in the calculation.
doi:10.1371/journal.pone.0013998.t004
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We observed a good adherence to intervention. In 34 of 51 (66%)
households of the intervention arm with follow-up information,
masks were worn more than 80% of the anticipated duration. We
did not identify any difference in adherence to mask use between
households with secondary illnesses and households without
secondary illness. Therefore we do not believe that a limited
adherence may explain our findings, contrarily to what has been
reported in other studies where less than 50% of the participants
were adherent to the intervention [3,6].
The analysis of other trials testing the efficacy of facemasks use
in households did not show a significant decrease of the secondary
illness rate in their primary intent-to-treat analyses [7]. Only one
trial evaluated masks worn by the index patient. In a secondary
analysis of this trial, household contacts of the intervention arm
including hand hygiene and face masks had lower rates of
secondary illness than the control arm if interventions were
applied quickly [3]. These results indicated that a substantial
proportion of influenza infection could be transmitted by other
routes than large droplets, and in particular via fomites or
contaminated surfaces. However, in this study, no additional
benefit was observed when facemask was added to hand hygiene
by comparison with hand hygiene alone. Our findings are
consistent with these results, suggesting a low effectiveness, if
any, of facemasks when used alone to limit influenza transmission
in a closed-setting.
We identified that younger contacts (#15 years) were more at
risk of ILI than adults which is consistent with results from other
studies [9,16,17]. The fact that women were more at risk for ILI
than men may have been due to the fact that women are more
often the caregiver in the households [17]. Finally, the fact that we
identified an association between symptoms and influenza
transmission is logical since patients with the more intense
symptoms are those who shed the highest viral load [18]. In
conclusion, although our findings did not suggest that face masks
could prevent transmission of influenza in households, the lack of
statistical power prevents us to draw a formal conclusion as to
exclude that face masks could nevertheless have a substantial
effect. Therefore our study should be interpreted cautiously as
providing additional data to other trials realized in the context of
seasonal epidemics.
Registering clinical trials
This study was registered with ClinicalTrials.gov, number
NCT: 00774774
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